Adeka Corp
TSE:4401
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 174.5
4 047
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Adeka Corp
In the bustling arena of global industries, Adeka Corp stands as a testament to the transformative power of innovation and diversification. Founded in 1917, this venerable Japanese company initially carved its niche as a producer of chemicals, agriculture, and food products—a juxtaposition that would seem eclectic, yet has proven remarkably synergetic. Over time, Adeka has honed its expertise within the chemical sector, manufacturing a plethora of products ranging from industrial chemicals and functional materials to fine chemicals. This diverse array not only includes essential raw materials pivotal for various industries but also advanced materials used in cutting-edge technologies. By integrating research and development directly into their operations, Adeka has maintained a competitive edge, ensuring their products meet the evolving demands of sectors such as electronics, automotive, and healthcare.
Meanwhile, the company's foray into food products highlights Adeka's astute responsiveness to consumer needs and market opportunities. Their food division manufactures premium margarine, shortening, and confectionery oils, serving both consumer and commercial markets. These culinary essentials have found a foothold in Japan’s gastronomic landscape, powering restaurants and households alike with high-quality ingredients. What ties these diverse segments together is Adeka's commitment to sustainability and efficiency in production processes, aligning their business model with global trends towards eco-conscious and health-focused solutions. Today, Adeka Corp deftly balances its diversified portfolio, generating revenue streams that capitalize on both industrial innovation and everyday consumer demands, ensuring its relevance in a rapidly transforming global market.
In the bustling arena of global industries, Adeka Corp stands as a testament to the transformative power of innovation and diversification. Founded in 1917, this venerable Japanese company initially carved its niche as a producer of chemicals, agriculture, and food products—a juxtaposition that would seem eclectic, yet has proven remarkably synergetic. Over time, Adeka has honed its expertise within the chemical sector, manufacturing a plethora of products ranging from industrial chemicals and functional materials to fine chemicals. This diverse array not only includes essential raw materials pivotal for various industries but also advanced materials used in cutting-edge technologies. By integrating research and development directly into their operations, Adeka has maintained a competitive edge, ensuring their products meet the evolving demands of sectors such as electronics, automotive, and healthcare.
Meanwhile, the company's foray into food products highlights Adeka's astute responsiveness to consumer needs and market opportunities. Their food division manufactures premium margarine, shortening, and confectionery oils, serving both consumer and commercial markets. These culinary essentials have found a foothold in Japan’s gastronomic landscape, powering restaurants and households alike with high-quality ingredients. What ties these diverse segments together is Adeka's commitment to sustainability and efficiency in production processes, aligning their business model with global trends towards eco-conscious and health-focused solutions. Today, Adeka Corp deftly balances its diversified portfolio, generating revenue streams that capitalize on both industrial innovation and everyday consumer demands, ensuring its relevance in a rapidly transforming global market.
Revenue Growth: Net sales for Q1 FY2025 reached JPY 101.6 billion, up JPY 3.4 billion year-over-year.
Operating Profit: Operating profit rose to JPY 10.9 billion, an increase of JPY 2.3 billion from last year.
Segment Performance: Life Science delivered significant growth, offsetting declines in Chemicals and Food Products segments.
Guidance Unchanged: Full-year forecasts for net sales and operating profit remain unchanged from May 2025 guidance.
Share Buyback: Announced share repurchase up to JPY 18 billion, running August 2025 to May 2026, aiming to boost shareholder returns.
Life Science Strength: Agrochemical sales were strong in Japan, North America, and Europe, driven by market conditions and tariffs.
International Sales: Overseas sales ratio remains high at just under 55%.